Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation, a global leader in minimally invasive treatments for severe lung disease, announced today […]
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company
Novo Integrated Sciences and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, has announced the […]
Alzheimer's Association Statement on Lecanemab Phase 3 Full Results
The Alzheimer’s Association welcomes, and is further encouraged by the full Phase 3 data presented […]
Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute
Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid […]
Vial Announces the Addition of Dr. Marc Hoffmann from the University of Kansas Medical Center to their Oncology CRO Scientific Advisory Board
Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Marc Hoffmann, […]
NHS Fast Tracks Life-Extending Prostate Cancer Drug to Patients
Around 9,000 men with one of the most advanced forms of prostate cancer will be […]
Chemotherapy May be Completed within 8 days with Two Doses of Polytaxel, an Innovative Anticancer Drug from South Korea's Biotech Firm
An innovative anticancer therapy that may complete chemotherapy with two doses of an anticancer drug […]
The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers […]
NHS To Roll Out Life-Extending Drug For Advanced Gastroesophageal Cancer
NHS comments on NICE decision to approve Nivolumab to treat rare forms of gastroesophageal cancer […]
Regeneron and CytomX Announce Strategic Research Collaboration for Cancer Treatment
Regeneron Pharmaceuticals and CytomX Therapeutics has announced a collaboration and licensing agreement to create conditionally-activated […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more